Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Anticoagulants industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Drug category trends
2.1.4 Route of administration trends
2.1.5 Application trends
2.1.6 Distribution channel trends
Chapter 3 Anticoagulants Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of chronic disease
3.2.1.2 Growing adoption of novel oral anticoagulants (NOACs)
3.2.1.3 Rising geriatric population across the globe
3.2.2 Industry pitfalls & challenges
3.2.2.1 High risk of side effects
3.2.2.2 Stringent regulatory framework
3.3 Growth potential analysis
3.3.1 By drug category
3.3.2 By route of administration
3.3.3 By application
3.3.4 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Anticoagulants Market Size and Forecast, By Drug Category (USD Million)
5.1 Key trends, by drug category
5.2 Factor Xa inhibitor
5.3 Heparin
5.4 Warfarin
5.5 Direct thrombin inhibitor
5.6 Others
Chapter 6 Anticoagulants Market Size and Forecast, By Route of Administration (USD Million)
6.1 Key trends, by route of administration
6.2 Oral
6.3 Injectable
Chapter 7 Anticoagulants Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Venous thromboembolism
7.3 Atrial fibrillation/flutter
7.4 Coronary artery disease
7.5 Others
Chapter 8 Anticoagulants Market Size and Forecast, By Distribution Channel (USD Million)
8.1 Key trends, by distribution channel
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy
Chapter 9 Anticoagulants Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Bristol-Myers Squibb Company
10.2 Bayer AG
10.3 Boehringer Ingelheim
10.4 Johnson and Johnson
10.5 Daiichi Sankyo Company
10.6 Amphastar Pharmaceuticals, Inc.
10.7 Leo pharma
10.8 Pfizer
10.9 ROVI
10.10 Sanofi
10.11 Shenzhen Hepalink
10.12 United Therapeutics
Anticoagulants Market Size
Anticoagulants Market size accounted for more than USD 39.2 billion in 2022 and is estimated to grow at a CAGR of over 9.5% from 2023 to 2032. Driven by the surging occurrence of chronic disorders worldwide.
Rising prevalence of chronic disorders such as deep vein thrombosis, and cardiovascular diseases which lead to blood clot formation has increased the need for anticoagulants. As per CDC, although the precise number of people diagnosed with deep vein thrombosis remains obscure, the condition can affect around 900,000 people every year in the U.S. alone. Moreover, the rising adoption of novel oral anticoagulants (NOACs) will further create a plethora of opportunities for market expansion. Benefits such as the rapid onset action, shorter half-life, and predictable pharmacokinetic action, have bolstered the adoption of NOACs.
COVID-19 Impact
The COVID-19 pandemic had a moderate impact on the anticoagulants market owing to supply chain disruptions caused by prolonged lockdowns. However, the surging prevalence of venous thromboembolism that led to blood clots in the veins of COVID-19 patients increased product uptake. For instance, in January 2021, WHO rolled-out a recommendation stating patients diagnosed with COVID-19, including confirmed and suspected cases, should have access to follow-up care with low-dose anticoagulants.
Anticoagulants Market Trends
Recent breakthroughs in genetic testing and pharmacogenomics will positively impact the industry landscape through 2032. These advancements have paved the way for personalized medicine approaches in anticoagulation therapy. Genetic variations can influence an individual's response to anticoagulant medications, including the risk of bleeding or thrombotic events. Tailoring the choice and dosing of anticoagulants based on a patient's genetic profile can significantly improve treatment outcomes and reduce adverse events.
Anticoagulants Market Analysis
Based on the drug category, the anticoagulants market revenue from the Factor Xa inhibitor segment will reach USD 58.4 billion by 2032. High availability of Factor Xa inhibitors globally is contributing to segment growth. These drugs can lower the risk of stroke and venous thrombosis. Additionally, people taking them do not require frequent blood tests.
With respect to application, the anticoagulants market from coronary heart disease segment was worth over USD 21.8 billion in 2022. Growing prevalence of coronary heart disease attributed to the surging adoption of a sedentary lifestyle has increased the need for anticoagulants. As per the National Institutes of Health, coronary artery disease affects around 18.2 million American adults, making it the most common heart disease in the U.S. In addition, surging elderly population that is highly susceptible to this disorder will further increase product uptake.
North America held approximately 60.5% of the anticoagulants market share in 2022. Growing healthcare spending in the region is positively impacting industry landscape. Moreover, the rising burden of cardiovascular disorders has further increased the need for anticoagulants in the region. North America is also home to major industry players such as Johnson and Johnson, Pfizer, and others focusing on product innovations to extend their footprint.
Anticoagulants Market Share
Anticoagulants Industry News:
This anticoagulants market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million & Tons) from 2018 to 2032, for the following segments:
By Drug Category
By Route of Administration
By Application
By Distribution Channel
The above information is provided for the following regions and countries: